Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ophthalmology | 11 | 2023 | 508 | 2.760 |
Why?
|
Oculomotor Muscles | 12 | 2022 | 371 | 2.200 |
Why?
|
Oculomotor Nerve Diseases | 5 | 2022 | 48 | 1.700 |
Why?
|
Eye Injuries | 6 | 2023 | 245 | 1.640 |
Why?
|
Vision, Binocular | 9 | 2022 | 213 | 1.400 |
Why?
|
Strabismus | 6 | 2022 | 287 | 1.390 |
Why?
|
Eye Diseases | 4 | 2022 | 669 | 1.360 |
Why?
|
Hyphema | 4 | 2021 | 26 | 1.330 |
Why?
|
Eye Injuries, Penetrating | 4 | 2022 | 115 | 1.320 |
Why?
|
Ophthalmologic Surgical Procedures | 11 | 2022 | 349 | 1.320 |
Why?
|
Retinoblastoma | 6 | 2023 | 318 | 1.310 |
Why?
|
Esotropia | 4 | 2022 | 91 | 1.050 |
Why?
|
Brain Concussion | 6 | 2022 | 1320 | 1.040 |
Why?
|
Exotropia | 2 | 2022 | 55 | 0.990 |
Why?
|
Post-Concussion Syndrome | 3 | 2022 | 219 | 0.970 |
Why?
|
Convergence, Ocular | 2 | 2021 | 24 | 0.880 |
Why?
|
Ocular Hypertension | 2 | 2021 | 198 | 0.800 |
Why?
|
Ocular Motility Disorders | 2 | 2022 | 135 | 0.800 |
Why?
|
Cataract | 2 | 2022 | 834 | 0.790 |
Why?
|
Botulinum Toxins, Type A | 4 | 2022 | 213 | 0.730 |
Why?
|
Accommodation, Ocular | 2 | 2021 | 48 | 0.730 |
Why?
|
Retinal Neoplasms | 4 | 2023 | 144 | 0.720 |
Why?
|
Athletic Injuries | 4 | 2022 | 1154 | 0.690 |
Why?
|
Telemedicine | 5 | 2023 | 2872 | 0.660 |
Why?
|
Timolol | 1 | 2017 | 52 | 0.600 |
Why?
|
Granuloma, Pyogenic | 1 | 2017 | 48 | 0.580 |
Why?
|
Conjunctival Diseases | 1 | 2017 | 122 | 0.540 |
Why?
|
Orbit | 3 | 2021 | 426 | 0.520 |
Why?
|
Periosteum | 1 | 2014 | 138 | 0.470 |
Why?
|
Infarction | 1 | 2014 | 244 | 0.450 |
Why?
|
Body Fluids | 1 | 2014 | 319 | 0.440 |
Why?
|
Nose | 2 | 2022 | 509 | 0.420 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1240 | 0.390 |
Why?
|
Polymers | 1 | 2017 | 1621 | 0.350 |
Why?
|
Melphalan | 3 | 2017 | 431 | 0.330 |
Why?
|
Lens, Crystalline | 2 | 2014 | 388 | 0.330 |
Why?
|
Glaucoma | 2 | 2022 | 1159 | 0.330 |
Why?
|
Biocompatible Materials | 1 | 2017 | 1736 | 0.320 |
Why?
|
Phacoemulsification | 1 | 2010 | 149 | 0.310 |
Why?
|
Lens Implantation, Intraocular | 1 | 2010 | 192 | 0.310 |
Why?
|
Child | 24 | 2023 | 77709 | 0.290 |
Why?
|
Anemia, Sickle Cell | 1 | 2014 | 1018 | 0.280 |
Why?
|
Retrospective Studies | 21 | 2023 | 77449 | 0.270 |
Why?
|
Macular Edema | 1 | 2010 | 359 | 0.270 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 2219 | 0.260 |
Why?
|
Visual Acuity | 4 | 2021 | 2530 | 0.240 |
Why?
|
Paralysis | 2 | 2022 | 247 | 0.230 |
Why?
|
Neuromuscular Agents | 2 | 2022 | 134 | 0.220 |
Why?
|
Cytomegalovirus Retinitis | 1 | 2022 | 58 | 0.220 |
Why?
|
Eye Pain | 1 | 2022 | 47 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
Hydrophthalmos | 1 | 2022 | 24 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.200 |
Why?
|
Humans | 56 | 2023 | 744343 | 0.200 |
Why?
|
Wounds, Nonpenetrating | 2 | 2021 | 794 | 0.190 |
Why?
|
Botulinum Toxins | 1 | 2022 | 191 | 0.190 |
Why?
|
Internship and Residency | 4 | 2022 | 5788 | 0.190 |
Why?
|
Diabetic Retinopathy | 1 | 2010 | 1210 | 0.190 |
Why?
|
Intraocular Pressure | 3 | 2022 | 1270 | 0.180 |
Why?
|
Trabeculectomy | 1 | 2022 | 160 | 0.180 |
Why?
|
Amblyopia | 1 | 2022 | 143 | 0.180 |
Why?
|
Sports Medicine | 1 | 2022 | 225 | 0.180 |
Why?
|
Hamartoma | 1 | 2022 | 238 | 0.180 |
Why?
|
School Admission Criteria | 1 | 2020 | 105 | 0.180 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2014 | 627 | 0.180 |
Why?
|
Injections, Intramuscular | 2 | 2018 | 552 | 0.170 |
Why?
|
Uveitis | 1 | 2022 | 375 | 0.170 |
Why?
|
Antifibrinolytic Agents | 1 | 2021 | 254 | 0.170 |
Why?
|
Personnel Selection | 1 | 2020 | 189 | 0.160 |
Why?
|
Lighting | 1 | 2020 | 231 | 0.150 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2020 | 245 | 0.150 |
Why?
|
Pyridoxaminephosphate Oxidase | 1 | 2017 | 8 | 0.150 |
Why?
|
Child, Preschool | 10 | 2023 | 41006 | 0.150 |
Why?
|
Fisheries | 1 | 2017 | 34 | 0.150 |
Why?
|
Brain Diseases, Metabolic | 1 | 2017 | 42 | 0.150 |
Why?
|
Central Serous Chorioretinopathy | 1 | 2017 | 27 | 0.150 |
Why?
|
Vulnerable Populations | 1 | 2022 | 687 | 0.150 |
Why?
|
Eye Foreign Bodies | 1 | 2017 | 55 | 0.150 |
Why?
|
Anterior Chamber | 1 | 2017 | 197 | 0.140 |
Why?
|
Fellowships and Scholarships | 2 | 2022 | 1076 | 0.140 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2020 | 397 | 0.140 |
Why?
|
Clinical Competence | 3 | 2022 | 4687 | 0.140 |
Why?
|
Drug Implants | 1 | 2017 | 244 | 0.140 |
Why?
|
Sports | 1 | 2022 | 688 | 0.140 |
Why?
|
Confidentiality | 1 | 2020 | 612 | 0.130 |
Why?
|
Computer-Assisted Instruction | 1 | 2019 | 365 | 0.130 |
Why?
|
Retinal Diseases | 1 | 2022 | 683 | 0.130 |
Why?
|
Stomatognathic System | 1 | 2014 | 4 | 0.130 |
Why?
|
Administration, Topical | 1 | 2017 | 690 | 0.130 |
Why?
|
Clavulanic Acid | 1 | 2014 | 19 | 0.130 |
Why?
|
Edema | 2 | 2021 | 789 | 0.130 |
Why?
|
Blue Toe Syndrome | 1 | 2014 | 4 | 0.120 |
Why?
|
Pupil Disorders | 1 | 2014 | 33 | 0.120 |
Why?
|
Leukemia | 1 | 2022 | 1511 | 0.120 |
Why?
|
Retinopathy of Prematurity | 1 | 2019 | 421 | 0.120 |
Why?
|
Male | 25 | 2023 | 350118 | 0.120 |
Why?
|
Amnion | 1 | 2015 | 209 | 0.120 |
Why?
|
Documentation | 1 | 2020 | 871 | 0.120 |
Why?
|
Pandemics | 4 | 2023 | 8388 | 0.120 |
Why?
|
Cross-Sectional Studies | 5 | 2022 | 25043 | 0.120 |
Why?
|
Educational Measurement | 1 | 2020 | 1210 | 0.120 |
Why?
|
Drug Synergism | 1 | 2018 | 1792 | 0.120 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2017 | 333 | 0.120 |
Why?
|
Amoxicillin | 1 | 2014 | 170 | 0.120 |
Why?
|
Adolescent | 10 | 2022 | 85781 | 0.110 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13695 | 0.110 |
Why?
|
Delayed-Action Preparations | 1 | 2017 | 968 | 0.110 |
Why?
|
Metals | 1 | 2017 | 719 | 0.110 |
Why?
|
Gait | 1 | 2018 | 793 | 0.110 |
Why?
|
Infant | 7 | 2022 | 35136 | 0.110 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2015 | 280 | 0.100 |
Why?
|
Optic Nerve | 2 | 2021 | 554 | 0.100 |
Why?
|
Mass Casualty Incidents | 1 | 2014 | 183 | 0.100 |
Why?
|
Orbital Diseases | 1 | 2013 | 181 | 0.100 |
Why?
|
Vision Disorders | 1 | 2018 | 1058 | 0.090 |
Why?
|
Leukocyte Count | 1 | 2014 | 1588 | 0.090 |
Why?
|
History, 21st Century | 1 | 2017 | 1534 | 0.090 |
Why?
|
Periodicals as Topic | 1 | 2022 | 1432 | 0.090 |
Why?
|
Catheterization, Peripheral | 1 | 2014 | 345 | 0.090 |
Why?
|
Blast Injuries | 1 | 2014 | 302 | 0.090 |
Why?
|
Treatment Outcome | 9 | 2022 | 63114 | 0.090 |
Why?
|
Internet | 1 | 2022 | 3064 | 0.090 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2013 | 547 | 0.090 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2013 | 604 | 0.090 |
Why?
|
Female | 19 | 2023 | 380194 | 0.090 |
Why?
|
Triamcinolone Acetonide | 1 | 2010 | 101 | 0.090 |
Why?
|
History, 20th Century | 1 | 2017 | 2740 | 0.080 |
Why?
|
Eye Movements | 2 | 2022 | 507 | 0.080 |
Why?
|
Hemangioma | 1 | 2013 | 738 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2133 | 0.080 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2009 | 73 | 0.080 |
Why?
|
United States | 6 | 2023 | 69872 | 0.080 |
Why?
|
Laser Coagulation | 1 | 2010 | 326 | 0.080 |
Why?
|
Face | 1 | 2013 | 994 | 0.080 |
Why?
|
Pediatrics | 1 | 2022 | 3475 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2022 | 39050 | 0.070 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3229 | 0.070 |
Why?
|
Brain Infarction | 1 | 2009 | 299 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8642 | 0.070 |
Why?
|
Proteins | 1 | 2020 | 6103 | 0.060 |
Why?
|
Income | 1 | 2023 | 1913 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5319 | 0.060 |
Why?
|
Seizures | 1 | 2017 | 2859 | 0.060 |
Why?
|
Blindness | 1 | 2009 | 617 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6489 | 0.060 |
Why?
|
Fossil Fuels | 1 | 2023 | 44 | 0.060 |
Why?
|
Adult | 8 | 2023 | 214055 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 2014 | 1917 | 0.050 |
Why?
|
Fixation, Ocular | 1 | 2003 | 251 | 0.050 |
Why?
|
Epilepsy | 1 | 2017 | 3310 | 0.050 |
Why?
|
Optics and Photonics | 1 | 2003 | 321 | 0.050 |
Why?
|
Developing Countries | 1 | 2023 | 2815 | 0.050 |
Why?
|
Vitreous Body | 1 | 2022 | 389 | 0.050 |
Why?
|
Saccades | 1 | 2022 | 246 | 0.050 |
Why?
|
Glucocorticoids | 1 | 2010 | 2107 | 0.050 |
Why?
|
Inflammation | 1 | 2020 | 10638 | 0.050 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2038 | 0.040 |
Why?
|
Endocrine System | 1 | 2020 | 113 | 0.040 |
Why?
|
Lipomatosis | 1 | 2020 | 112 | 0.040 |
Why?
|
Carbon Dioxide | 1 | 2023 | 1150 | 0.040 |
Why?
|
Specialty Boards | 1 | 2020 | 227 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2010 | 3508 | 0.040 |
Why?
|
Cohort Studies | 1 | 2021 | 40561 | 0.040 |
Why?
|
Bone Marrow Diseases | 1 | 2020 | 231 | 0.040 |
Why?
|
Bibliometrics | 1 | 2022 | 339 | 0.040 |
Why?
|
Pyridoxal Phosphate | 1 | 2017 | 127 | 0.040 |
Why?
|
Environment | 1 | 2023 | 1124 | 0.040 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2009 | 2737 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 1 | 2022 | 2559 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7181 | 0.030 |
Why?
|
Young Adult | 4 | 2023 | 56430 | 0.030 |
Why?
|
Acute Disease | 2 | 2017 | 7149 | 0.030 |
Why?
|
Feedback | 1 | 2019 | 795 | 0.030 |
Why?
|
Eye Enucleation | 1 | 2014 | 128 | 0.030 |
Why?
|
Sirolimus | 1 | 2022 | 1564 | 0.030 |
Why?
|
Explosive Agents | 1 | 2014 | 26 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2013 | 5686 | 0.030 |
Why?
|
Bombs | 1 | 2014 | 72 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2017 | 35421 | 0.030 |
Why?
|
Injections, Intra-Arterial | 1 | 2013 | 193 | 0.030 |
Why?
|
Prospective Studies | 2 | 2023 | 53288 | 0.030 |
Why?
|
Texas | 1 | 2014 | 392 | 0.030 |
Why?
|
Disease Progression | 1 | 2010 | 13284 | 0.030 |
Why?
|
Exophthalmos | 1 | 2013 | 97 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9274 | 0.030 |
Why?
|
Sclera | 1 | 2014 | 200 | 0.030 |
Why?
|
Particulate Matter | 1 | 2023 | 2530 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20129 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 12804 | 0.020 |
Why?
|
Middle Aged | 4 | 2022 | 213383 | 0.020 |
Why?
|
General Surgery | 1 | 2022 | 1636 | 0.020 |
Why?
|
Hyperplasia | 1 | 2013 | 1185 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 2987 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 2291 | 0.020 |
Why?
|
Eye | 1 | 2013 | 729 | 0.020 |
Why?
|
Thrombocytosis | 1 | 2009 | 81 | 0.020 |
Why?
|
Ophthalmic Artery | 1 | 2009 | 60 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2021 | 6993 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 21746 | 0.020 |
Why?
|
Fundus Oculi | 1 | 2009 | 473 | 0.020 |
Why?
|
Registries | 1 | 2023 | 8089 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3638 | 0.020 |
Why?
|
Databases, Factual | 1 | 2022 | 7729 | 0.020 |
Why?
|
Retina | 1 | 2017 | 2616 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8663 | 0.020 |
Why?
|
Primary Health Care | 1 | 2022 | 4558 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10388 | 0.020 |
Why?
|
Optic Nerve Diseases | 1 | 2009 | 327 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 20947 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10943 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 3923 | 0.010 |
Why?
|
Mutation | 2 | 2020 | 29786 | 0.010 |
Why?
|
Birefringence | 1 | 2003 | 56 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2618 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16365 | 0.010 |
Why?
|
Risk Factors | 2 | 2023 | 72290 | 0.010 |
Why?
|
Electroencephalography | 1 | 2017 | 6150 | 0.010 |
Why?
|
Functional Laterality | 1 | 2009 | 2290 | 0.010 |
Why?
|
Boston | 1 | 2014 | 9313 | 0.010 |
Why?
|
Automation | 1 | 2003 | 584 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 13881 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2009 | 2731 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 25625 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18370 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40075 | 0.010 |
Why?
|
Equipment Design | 1 | 2003 | 3582 | 0.010 |
Why?
|
Prognosis | 1 | 2014 | 29063 | 0.010 |
Why?
|
Aged | 1 | 2021 | 163280 | 0.010 |
Why?
|
Hypertension | 1 | 2009 | 8480 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2009 | 57776 | 0.000 |
Why?
|
Concepts
(230)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(64)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_